Combined statin and fenofibrate therapy and cardiorenal outcomes in patients with CKD, dyslipidemia, and…

Network and pairwise meta-analysis of the effects of novel hypoglycemic agents on cardiorenal outcomes in patients with type 2 diabetes and heart failure
Xuejiao Ye, Qian Wu, Leyang Li +2
Frontiers in Endocrinology14 Oct 2026Peer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMCPMC
Combined statin probiotic treatment mitigates atherogenic dyslipidemia fueling NAFLD in high-cholesterol-diet fed rats
A. Rajkumar, P. Elangovan, G. Panchalingam +3
bioRxiv15 Oct 2026PreprintAll rights reservedFull textSurgery & anaesthesiabioRxiv
Dose-dependent efficacy and renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridemia: a multicenter randomized controlled, open label trial
Michihiro Iwaki, Hiroshi Tobita, Yuya Seko +38
eClinicalMedicine1 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
Clinical Outcomes of Combined TAVR-PCI Versus SAVR-CABG in Patients with Aortic Stenosis and Coronary Artery Disease: A Systematic Review and Meta-Analysis
Ricardo Antonio Rodriguez Mejia, Mathhar Aldaoud, Ifeanyi Momodu +6
Journal of clinical medicine29 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Association Between the Naples Prognostic Score and In-Hospital Mortality in Patients with Type 2 Cardiorenal Syndrome: A Retrospective Cohort Study
Eren Eynel, Emre Eynel, Yusuf Can
Diagnostics (Basel, Switzerland)30 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{anon2026combined,
  title = {{Combined statin and fenofibrate therapy and cardiorenal outcomes in patients with CKD, dyslipidemia, and ischemic heart disease}},
  journal = {Clinical kidney journal},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655736},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Combined statin and fenofibrate therapy and cardiorenal outcomes in patients with CKD, dyslipidemia, and ischemic heart disease
PY  - 2026
DA  - 2026/10/01
JO  - Clinical kidney journal
UR  - https://europepmc.org/article/PMC/PMC13655736
SN  - 2048-8505
SN  - 2048-8513
ER  -

Related

Cite